395 related articles for article (PubMed ID: 17387151)
1. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.
McVay CS; Velásquez M; Fralick JA
Antimicrob Agents Chemother; 2007 Jun; 51(6):1934-8. PubMed ID: 17387151
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa.
Dale RM; Schnell G; Wong JP
Antimicrob Agents Chemother; 2004 Aug; 48(8):2918-23. PubMed ID: 15273101
[TBL] [Abstract][Full Text] [Related]
4. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
Felts AG; Giridhar G; Grainger DW; Slunt JB
Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
7. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients.
Marza JA; Soothill JS; Boydell P; Collyns TA
Burns; 2006 Aug; 32(5):644-6. PubMed ID: 16781080
[No Abstract] [Full Text] [Related]
8. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Coetzee E; Rode H; Kahn D
S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.
Tiwari BR; Kim S; Rahman M; Kim J
J Microbiol; 2011 Dec; 49(6):994-9. PubMed ID: 22203564
[TBL] [Abstract][Full Text] [Related]
11. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage.
Hagens S; Habel A; Bläsi U
Microb Drug Resist; 2006; 12(3):164-8. PubMed ID: 17002542
[TBL] [Abstract][Full Text] [Related]
13. Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model Assays.
Holguín AV; Rangel G; Clavijo V; Prada C; Mantilla M; Gomez MC; Kutter E; Taylor C; Fineran PC; Barrios AF; Vives MJ
Viruses; 2015 Aug; 7(8):4602-23. PubMed ID: 26274971
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
Krylov VN
Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
[TBL] [Abstract][Full Text] [Related]
15. Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.
Beeton ML; Alves DR; Enright MC; Jenkins AT
Int J Antimicrob Agents; 2015 Aug; 46(2):196-200. PubMed ID: 26100212
[TBL] [Abstract][Full Text] [Related]
16. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
[TBL] [Abstract][Full Text] [Related]
17. Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.
Pires DP; Vilas Boas D; Sillankorva S; Azeredo J
J Virol; 2015 Aug; 89(15):7449-56. PubMed ID: 25972556
[TBL] [Abstract][Full Text] [Related]
18. Improving the Inhibitory Effect of Phages against
Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Naqvi SH; Naqvi SH
S Afr J Surg; 2013 Oct; 51(4):151-2. PubMed ID: 24209702
[No Abstract] [Full Text] [Related]
20. Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
Yang M; Du C; Gong P; Xia F; Sun C; Feng X; Lei L; Song J; Zhang L; Wang B; Xiao F; Yan X; Cui Z; Li X; Gu J; Han W
Res Microbiol; 2015 Oct; 166(8):633-43. PubMed ID: 26254772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
